New heart failure therapy for patients with reduced ejection fraction: Entresto recommended by CHMP for European Union approval
The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion for Entresto ( Sacubitril / Valsartan ). Pending final approval by the European Commission ( EC ) Entresto, p ...
read article